Research table: Weight gain and breast cancer risk
This summary table contains detailed information about research studies. Summary tables are a useful way to look at the science behind many breast cancer guidelines and recommendations. However, to get the most out of the tables, it’s important to understand some key concepts. Learn how to read a research table. |
Introduction: Weight gain in adulthood is linked to an increased risk of breast cancer after menopause.
Whether weight gain in adulthood is linked to the risk of breast cancer before menopause is under study.
Learn more about weight gain and breast cancer risk.
Learn about the strengths and weaknesses of different types of studies.
See how this risk factor compares with other risk factors for breast cancer.
* Please note, the information provided within Komen Perspectives articles is only current as of the date of posting. Therefore, some information may be out of date.
Study selection criteria: Prospective cohort studies with at least 1,000 breast cancer cases, pooled analyses and meta-analyses.
Table note: Relative risk above 1 indicates increased risk. Relative risk below 1 indicates decreased risk.
Menopausal hormone therapy (MHT) is FDA-approved for the short-term relief of menopausal symptoms. Women who use MHT have an increased risk of breast cancer. This increased breast cancer risk related to MHT may make it difficult to see an increased risk related to body weight in study data. For this reason, many studies report findings by MHT use. MHT may also be called postmenopausal hormone therapy or hormone replacement therapy (HRT).
Learn more about MHT and breast cancer risk.
Study |
Study Population |
Follow-up |
Time of Weight Gain |
Categories of Weight Gain Compared |
Relative Risk of Breast Cancer in Women who Gained the Most Weight Compared to Women who Gained the Least, |
|
Before Menopause |
After Menopause |
|||||
Prospective cohort studies | ||||||
Nurses’ Health Study [1-2] |
74,177 |
22† |
From age |
11 to less than 22 lbs. |
1.03 |
1.08 |
|
|
|
|
22 to less than 33 lbs. |
1.05 |
1.25 |
|
|
|
|
33 to less than 44 lbs. |
1.00 |
1.23 |
|
|
|
|
More than 44 lbs. |
1.05 |
1.17 |
|
49,514 |
24 |
From age at menopause |
22 lbs. or more |
|
1.18 |
Women’s Health Initiative Observational Study [3] |
70,397 |
25 |
From age |
More than 11 lbs. |
|
1.15 |
EPIC Cohort [4-5] |
150,257 |
14 |
From age |
11-22 lbs. |
1.03 |
1.01 |
|
|
|
|
More than 22 lbs. |
0.99 |
1.40 |
|
205,723 |
8 |
From age |
9-55 lbs. |
1.37 |
1.24 |
California Teachers Study [6] |
109,862 |
13-14 |
From age 18 |
10-24 lbs. |
|
1.42 |
|
|
|
|
25 lbs. or more |
1.04 |
|
Multiethnic Cohort [7] |
82,971 |
8-11 |
From age 21 |
20.1-31 |
1.13 |
|
31.1-49.9 |
1.23 |
|||||
50 or more |
1.39 |
|||||
Iowa Women’s Health Study [8] |
36,658 |
16 |
From age 18 |
29-45 |
Age 55-64: Age 65-74: Age 75-84: |
|
More than 45 |
Age 55-64: Age 65-74: Age 75-84: |
|||||
NIH-AARP Diet and Health Study [9] |
99,039 |
4 |
From age 18 |
66-88 lbs. |
1.87 |
|
|
From age 50 |
66-88 lbs. |
1.89 |
|||
|
Between ages 35-50 |
66-88 lbs. |
2.29 |
|||
Cancer Prevention Study-II (CPS-II) [10] |
65,756 |
7-9 |
From age 18 | 71 lbs. or more |
2.13 |
|
Nurses’ Health Study and Nurses’ Health Study II [11] |
165,608 |
14-28 |
From age 18 |
33-43.9 lbs. |
0.86 |
|
|
44-54.9 lbs. |
0.88 |
||||
55 lbs. or more |
0.74 |
|||||
CPS-II [12] |
44,161 |
9 |
From age 18 |
21-40 |
Ductal carcinoma: Lobular and mixed ductal/lobular carcinoma: |
|
41-60 |
Ductal carcinoma: Lobular and mixed ductal/lobular carcinoma: |
|||||
61 or more |
Ductal carcinoma: Lobular and mixed ductal/lobular carcinoma: |
|||||
PROCRAS Study (UK) [13] | 47,042 |
6 |
From age 20 |
11-21 |
0.90 |
1.41 |
|
|
|
|
22-43 |
1.23 |
1.62 |
|
|
|
|
44 or more |
1.28 |
2.01 |
Black Women’s Health Study [14] |
52,080 |
10 |
From age 18 |
55 or more |
1.17 |
1.09 |
Pooled and meta-analyses | ||||||
van den Brandt et al. [15] |
1,061,915 |
From ages 18-20 to study entry |
22-43 |
1.07 |
1.42 |
|
|
|
From ages 18-20 to study entry |
44 lbs. or more |
0.85 |
1.68 |
|
Schoemaker et al. [16] |
628,463 |
From ages 18-24 to ages 35-44 |
22-43 |
0.89 |
|
|
|
|
From ages 18-24 to ages 45-54 |
22-43 |
0.86 |
|
|
|
|
From ages 25-34 to ages 45-54 |
22-43 |
0.90 |
|
|
|
|
From ages 35-44 to ages 45-54 |
22-43 |
1.08 |
|
|
Vrieling et al. [17] |
7 studies |
From age 18†† |
Various |
For hormone receptor-positive tumors: For hormone receptor-negative tumors: |
† Estimated from person-years.
‡ Results are for women who never used menopausal hormone therapy (MHT).
§ All breast cancers were estrogen receptor-positive.
|| Relative risk for women who never used MHT. Among MHT users, there was no increase in risk.
¶ Results are for women not currently taking MHT.
** Results for women who gained 44 pounds or more were similar.
†† Five of 7 studies measured weight gain from age 18. One study measured weight gain from age 20 and one study measured weight gain from age 50.
References
- Rosner B, Eliassen AH, Toriola AT, et al. Weight and weight changes in early adulthood and later breast cancer risk. Int J Cancer. 140(9):2003-2014, 2017.
- Eliassen AH, Colditz GA, Rosner B, et al. Adult weight change and risk of postmenopausal breast cancer. JAMA. 296(2):193-201, 2006.
- Luo J, Chen X, Manson JE,et al. Birth weight, weight over the adult life course and risk of breast cancer. Int J Cancer. 147(1):65-75, 2020.
- Ellingjord-Dale M, Christakoudi S, Weiderpass E, et al. Long-term weight change and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Int J Epidemiol. 50(6):1914-1926, 2022.
- Emaus MJ, van Gils CH, Bakker MF, et al. Weight change in middle adulthood and breast cancer risk in the EPIC-PANACEA study. Int J Cancer. 135(12):2887-99, 2014.
- Horn-Ross PL, Canchola AJ, Bernstein L, Neuhausen SL, Nelson DO, Reynolds P. Lifetime body size and estrogen-receptor-positive breast cancer risk in the California Teachers Study cohort. Breast Cancer Res. 18(1):132, 2016.
- White KK, Park SY, Kolonel LN, Henderson BE, Wilkens LR. Body size and breast cancer risk: The multiethnic cohort. Int J Cancer. 131(5):E705-16, 2012.
- Sweeney C, Blair CK, Anderson KE, et al. Risk factors of breast cancer in elderly women. Am J Epidemiol. 160(9):868-75, 2004.
- Ahn J, Schatzkin A, Lacey JV Jr, et al. Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch Intern Med. 167(19):2091-102, 2007.
- Feigelson HS, Jonas CR, Teras LR, Thun MJ, Calle EE. Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev. 13(2):220-4, 2004.
- Michels KB, Terry KL, Eliassen AH, Hankinson SE, Willett WC. Adult weight change and incidence of premenopausal breast cancer. Int J Cancer. 130(4):902-9, 2012.
- Feigelson HS, Patel AV, Teras LR, et al. Adult weight gain and histopathologic characteristics of breast cancer among postmenopausal women. Cancer. 107(1):12-21, 2006.
- Renehan AG, Pegington M, Harvie MN, et al. Young adulthood body mass index, adult weight gain and breast cancer risk: the PROCAS Study (United Kingdom). Br J Cancer. 122(10):1552-1561, 2020.
- Palmer JR, Adams-Campbell LL, Boggs DA, Wise LA, Rosenberg L. A prospective study of body size and breast cancer in black women. Cancer Epidemiol Biomarkers Prev. 16(9):1795-802, 2007.
- van den Brandt PA, Ziegler RG, Wang M, et al. Body size and weight change over adulthood and risk of breast cancer by menopausal and hormone receptor status: a pooled analysis of 20 prospective cohort studies. Eur J Epidemiol. 36(1):37-55, 2021.
- Schoemaker MJ, Nichols HB, Wright LB, et al. Adult weight change and premenopausal breast cancer risk: A prospective pooled analysis of data from 628,463 women. Int J Cancer. 147(5):1306-1314, 2020.
- Vrieling A, Buck K, Kaaks R, Chang-Claude J. Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis. Breast Cancer Res Treat. 123(3):641-9, 2010.
Updated 06/05/24